SE0401578D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0401578D0 SE0401578D0 SE0401578A SE0401578A SE0401578D0 SE 0401578 D0 SE0401578 D0 SE 0401578D0 SE 0401578 A SE0401578 A SE 0401578A SE 0401578 A SE0401578 A SE 0401578A SE 0401578 D0 SE0401578 D0 SE 0401578D0
- Authority
- SE
- Sweden
- Prior art keywords
- hydrogen
- methyl
- fluoro
- chloro
- alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 7
- 239000001257 hydrogen Substances 0.000 abstract 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 4
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 3
- 125000001153 fluoro group Chemical group F* 0.000 abstract 3
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- 101100295741 Gallus gallus COR4 gene Proteins 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 230000005784 autoimmunity Effects 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001767 cationic compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 150000002892 organic cations Chemical class 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0401578A SE0401578D0 (sv) | 2004-06-18 | 2004-06-18 | Novel compounds |
| AT05753986T ATE375353T1 (de) | 2004-06-18 | 2005-06-15 | Thienopyridoncarbonsäureamide und deren medizinische verwendung |
| EP05753986A EP1776369B1 (de) | 2004-06-18 | 2005-06-15 | Thienopyridoncarbonsäureamide und deren medizinische verwendung |
| JP2007515955A JP4906718B2 (ja) | 2004-06-18 | 2005-06-15 | チエノピリドンカルボキサミド及びその医学的使用 |
| DE602005002847T DE602005002847T2 (de) | 2004-06-18 | 2005-06-15 | Thienopyridoncarbonsäureamide und deren medizinische verwendung |
| AU2005254731A AU2005254731B2 (en) | 2004-06-18 | 2005-06-15 | Thienopyridone carboxamides and their medical use |
| RU2007101702/04A RU2374250C2 (ru) | 2004-06-18 | 2005-06-15 | Тиенопиридон карбоксамиды и их применение в медицине |
| US11/152,777 US7553849B2 (en) | 2004-06-18 | 2005-06-15 | Compounds |
| CN2005800199955A CN1980937B (zh) | 2004-06-18 | 2005-06-15 | 噻吩并吡啶酮甲酰胺及其医药用途 |
| PCT/EP2005/052767 WO2005123744A1 (en) | 2004-06-18 | 2005-06-15 | Thienopyridone carboxamides and their medical use |
| ZA200609265A ZA200609265B (en) | 2004-06-18 | 2005-06-15 | Thienopyridone carboxamides and their medical use |
| ES05753986T ES2294721T3 (es) | 2004-06-18 | 2005-06-15 | Tienopiricarboxamidas y su utilizacion medica. |
| CA2570506A CA2570506C (en) | 2004-06-18 | 2005-06-15 | Thienopyridone carboxamides and their medical use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0401578A SE0401578D0 (sv) | 2004-06-18 | 2004-06-18 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0401578D0 true SE0401578D0 (sv) | 2004-06-18 |
Family
ID=32906817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0401578A SE0401578D0 (sv) | 2004-06-18 | 2004-06-18 | Novel compounds |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7553849B2 (de) |
| EP (1) | EP1776369B1 (de) |
| JP (1) | JP4906718B2 (de) |
| CN (1) | CN1980937B (de) |
| AT (1) | ATE375353T1 (de) |
| AU (1) | AU2005254731B2 (de) |
| CA (1) | CA2570506C (de) |
| DE (1) | DE602005002847T2 (de) |
| ES (1) | ES2294721T3 (de) |
| RU (1) | RU2374250C2 (de) |
| SE (1) | SE0401578D0 (de) |
| WO (1) | WO2005123744A1 (de) |
| ZA (1) | ZA200609265B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2813711A1 (en) * | 2010-10-14 | 2012-04-19 | Immunahr Ab | 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators. |
| CN102127091B (zh) * | 2010-12-30 | 2012-11-21 | 天津药物研究院 | 含有杂环的希夫碱化合物 |
| CA3119925A1 (en) * | 2018-11-20 | 2020-05-28 | The National Institutes Of Pharmaceutical Research And Development (Nip) | Spiro compound and medical uses thereof |
| CN114957278B (zh) * | 2021-02-20 | 2023-08-11 | 兰州大学 | 胰高血糖素受体拮抗剂及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5219864A (en) * | 1991-03-12 | 1993-06-15 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
| DE4227747A1 (de) * | 1992-08-21 | 1994-02-24 | Basf Ag | Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung |
| GB9311562D0 (en) | 1993-06-04 | 1993-07-21 | Fujisawa Pharmaceutical Co | Heterocyclic derivatives |
| DE4444815A1 (de) * | 1994-12-15 | 1996-06-20 | Merck Patent Gmbh | Thienopyridone |
| SE9801474D0 (sv) * | 1998-04-27 | 1998-04-27 | Active Biotech Ab | Quinoline Derivatives |
| SE9802550D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
| SE9802549D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
| JP2002539130A (ja) | 1999-03-09 | 2002-11-19 | ファルマシア・アンド・アップジョン・カンパニー | 抗ウイルス剤としての４−オキソ−４，７−ジヒドロ−チエノ［２，３−ｂ］ピリジン−５−カルボキサミド |
| SE0002320D0 (sv) * | 1999-10-25 | 2000-06-21 | Active Biotech Ab | Malignant tumors |
| PT1419772E (pt) | 2001-08-24 | 2007-09-05 | Dynogen Pharmaceuticals Inc | Agente preventivo/agente terapêutico papa ibs com predominância de obstipação. |
| AR038294A1 (es) | 2002-01-14 | 2005-01-12 | Upjohn Co | Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales |
| WO2004019939A1 (en) | 2002-08-30 | 2004-03-11 | Pharmacia & Upjohn Company | Method of preventing or treating atherosclerosis or restenosis |
-
2004
- 2004-06-18 SE SE0401578A patent/SE0401578D0/xx unknown
-
2005
- 2005-06-15 ZA ZA200609265A patent/ZA200609265B/en unknown
- 2005-06-15 CN CN2005800199955A patent/CN1980937B/zh not_active Expired - Fee Related
- 2005-06-15 JP JP2007515955A patent/JP4906718B2/ja not_active Expired - Fee Related
- 2005-06-15 WO PCT/EP2005/052767 patent/WO2005123744A1/en not_active Ceased
- 2005-06-15 DE DE602005002847T patent/DE602005002847T2/de not_active Expired - Lifetime
- 2005-06-15 AU AU2005254731A patent/AU2005254731B2/en not_active Ceased
- 2005-06-15 CA CA2570506A patent/CA2570506C/en not_active Expired - Fee Related
- 2005-06-15 RU RU2007101702/04A patent/RU2374250C2/ru not_active IP Right Cessation
- 2005-06-15 EP EP05753986A patent/EP1776369B1/de not_active Expired - Lifetime
- 2005-06-15 AT AT05753986T patent/ATE375353T1/de not_active IP Right Cessation
- 2005-06-15 ES ES05753986T patent/ES2294721T3/es not_active Expired - Lifetime
- 2005-06-15 US US11/152,777 patent/US7553849B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| RU2374250C2 (ru) | 2009-11-27 |
| JP2008502655A (ja) | 2008-01-31 |
| CN1980937B (zh) | 2011-08-10 |
| CA2570506A1 (en) | 2005-12-29 |
| US20060004038A1 (en) | 2006-01-05 |
| DE602005002847D1 (de) | 2007-11-22 |
| US7553849B2 (en) | 2009-06-30 |
| ZA200609265B (en) | 2008-05-28 |
| EP1776369B1 (de) | 2007-10-10 |
| CN1980937A (zh) | 2007-06-13 |
| JP4906718B2 (ja) | 2012-03-28 |
| AU2005254731A1 (en) | 2005-12-29 |
| DE602005002847T2 (de) | 2008-07-10 |
| WO2005123744A1 (en) | 2005-12-29 |
| ES2294721T3 (es) | 2008-04-01 |
| AU2005254731B2 (en) | 2010-10-21 |
| CA2570506C (en) | 2012-12-18 |
| EP1776369A1 (de) | 2007-04-25 |
| RU2007101702A (ru) | 2008-07-27 |
| ATE375353T1 (de) | 2007-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU1501A (sh) | Derivati hinolina | |
| NO20071921L (no) | Fremgangsmater for behandling av epileptogenese og epilepsi | |
| HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
| ECSP088179A (es) | Compuestos de carbamato para usarse en el tratamiento de desordenes neurodegenerativos | |
| SE9801474D0 (sv) | Quinoline Derivatives | |
| NO20080877L (no) | Fremgangsmater for behandling av substansrelaterte forstyrrelser | |
| CY1110145T1 (el) | Αλκυλο-υποκατεστημενες ινδολοκινοξαλινες | |
| MY157373A (en) | Carbamate compounds for use in preventing or treating movement disorders | |
| WO2009028387A1 (ja) | プロテアーゼ阻害剤耐性を有する癌の治療薬 | |
| DK1408953T3 (da) | Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom | |
| MY136391A (en) | Carbamate compounds for use in preventing or treating anxiety disorders | |
| SE0401578D0 (sv) | Novel compounds | |
| HRP20110780T1 (hr) | Aminoarilsulfonamidni spojevi i njihova upotreba kao ligandi 5-ht6 | |
| EA200700871A1 (ru) | Способы нейропротекции | |
| EA200700322A1 (ru) | Оксазолидиноны, содержащие оксиндолы, в качестве антибактериальных агентов | |
| MY136733A (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| PL422539A1 (pl) | Związki N-arylosulfonyloindolowe do leczenia chorób OUN | |
| TW200701978A (en) | Methods of treating epileptogenesis and epilepsy | |
| TH70879A (th) | อนุพันธ์ของ 5-(ไพริดิน-3-อิล)-1-แอซาไบไซโคล[3.2.1]ออกเทน, การเตรียมสาร และการประยุกต์ใช้สารในการบำบัดรักษา | |
| AR035699A1 (es) | Asociacion de al menos un derivado de piridoindolona, composicion farmaceutica que comprende al menos un derivado de piridoindolona y kit para el tratamiento de la proliferacion de celulas tumorales | |
| SE0401308D0 (sv) | Anordning för lampanslutning |